Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.

Corporate Documents

Type:

PDF

Date:

22 May 2020

Type:

PDF

Date:

22 May 2020

Type:

PDF

Date:

13 Jun 2019

Type:

PDF

Date:

01 Jan 1970

Type:

PDF

Date:

30 Apr 2019

Type:

PDF

Date:

30 Apr 2019

Type:

PDF

Date:

28 Sep 2018

Type:

PDF

Date:

05 Jun 2018

Type:

PDF

Date:

30 Jun 2017

Type:

PDF

Date:

28 Apr 2017

Type:

PDF

Date:

28 Apr 2017

Type:

PDF

Date:

04 Apr 2017

Type:

PDF

Date:

20 Sep 2016

Type:

PDF

Date:

20 Sep 2016

Type:

PDF

Date:

15 Jul 2016

Type:

PDF

Date:

30 Jun 2016

Type:

PDF

Date:

14 Jun 2016

Type:

PDF

Date:

12 Jun 2016

Type:

PDF

Date:

12 Jun 2016

Type:

PDF

Date:

12 Jun 2016

Type:

PDF

Date:

12 Jun 2016